Hi @Barry ,
To answer your question on whether all mothers are tested for hepatitis B, the short answer is that they are supposed to be (it is standard of care), but real-world data shows that in the US, the screening is done about 85% of the time, meaning that 15% of women are never tested. Also, transmission of hepatitis B in the womb is rare (though this can happen, especially if a procedure such as amniocentesis is performed), so for the vast majority of babies born to HBsAg positive mothers, their first exposure to the virus is at the time of birth. The rationale behind giving the vaccine at birth is that it can give the immune system enough of a boost to prevent the infection from taking hold. I actually think it’s pretty remarkable that the vaccine works as well as it does for post-exposure prophylaxis!
I also think that giving the vaccine to infants is the best way for us to get high vaccine coverage rates across the population. Like you said, adults with behavioural risk factors are not coming forward to get the vaccine, because many healthy adults don’t see their doctor regularly. I also think that if we do what you’re suggesting, and do away with official recommendations, and just rely on patients to make decisions for themselves, I think that we as patients need to take responsibility for those decisions, where we can’t really blame the doctors anymore for not recommending the vaccine if it’s not part of the standard of care. That’s also why I think it’s important to prioritize vaccinating infants/children, because babies don’t have any decision-making capacity of their own, so they rely on adults to protect them.
If we assumed hypothetically that adults and children were all equally likely to have an acute infection turn chronic, I would actually agree with your suggestion to focus on vaccinating adults. But that’s not what we see from the data. I also want to add that the protection from the hepatitis B vaccine lasts for several decades (possibly lifelong, but the current vaccines have only been around for ~40 years), so it’s likely that if it had been routine when you were a child, you would still be protected today.
I am adopted from China, and grew up in Toronto, Canada. Unfortunately, Canada does not have nationwide birth dose (or even infant) vaccination, though there are multiple groups trying to push for this. I found this paper showing the cost-effectiveness of infant (and birth dose) vaccination. The analyses here estimate that there are a non-negligible number of children who are not born to HBsAg-positive mothers, who are still catching hep B before age 10. That being said, I don’t think delaying the vaccine until 2 months old is the end of the world, especially if we still continue to vaccinate babies at birth if their mothers were not tested. It actually concerns me more that the current advisory committee is suggesting that people only need one dose of the hep B vaccine and should have their antibody levels tested to see if they need more. @chari.cohen also covered that in her interview, and the data suggest that if we move forward with that approach, only about 25% of people would develop protective immunity, and that immunity also may not be long-lasting (we don’t know because there are no longitudinal studies evaluating a single dose schedule).
Sorry for the long reply, but I hope this helps.